← Open Payments lookup

SAMUEL WEDES: Open Payments

NPI 1194031062 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,513 in 134 payments from 20 companies in 2025. Trend: 2023 $20,462 · 2024 $360 · 2025 $2,513

Food & beverage: $2,401Education: $111
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.17$294
E.R. Squibb & Sons, L.L.C.13$290
Teva Pharmaceuticals USA, Inc.7$246
ABBVIE INC.12$216
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$157
Collegium Pharmaceutical, Inc.9$155
Axsome Therapeutics, Inc.10$146
Corium, LLC10$127
Neurocrine BioSciences, Inc.6$124
Alkermes, Inc.4$119

Products named: REXULTI, COBENFY, VRAYLAR, CAPLYTA, Jornay PM, UZEDY, Azstarys, INGREZZA.

Industry payments across MI — which companies pay providers there.